18F-Aluminum-NOTA-octreotide
Image for illustration purposes only.
Used for neuroendocrine tumors diagnostic procedures, this radiopharmaceutical is consisted of a peptide like the natural hormone somatostatin, allowing the identification of endocrine receptors.
Manufactured and distributed by:
Duque de Caxias Location/RJ (Official letter No. 4499850223)
- Presentation: Shielded packaging containing 1 multidose vial.
- Pharmaceutical form: Sterile solution.
- Route of administration: Intravenous.
- Ingredients: Each vial of radiopharmaceutical contains up to 10 mL.
- Excipients: Each mL of solution contains up to 78.9 µg of ethanol and 3 mg of sodium.
- Physical half-life: 109.7 minutes.
- Indication: histologic diagnosis of neuroendocrine tumor scales I, II or III.
R2Pharma products are available only by means of medical prescription from a licensed physician.
IF SYMPTOMS PERSIST, A DOCTOR SHOULD BE CONSULTED.
Contraindications, warnings, adverse reactions, drug interactions, precautions and posology: refer to package leaflet.
The content of this page is destined to health professionals.